发明名称 TEST KITS
摘要 This invention relates to prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for colorectal cancer. Specifically, this invention relates to the use of genetic markers for the prediction of the prognosis of cancer, such as colorectal cancer, based on signatures of genetic markers. In various aspects, the invention relates to a method of predicting the likelihood of long-term survival of a cancer patient, a method of determining a treatment regime for a cancer patient, a method of preparing a treatment modality for a cancer patient, among other methods as well as kits and devices for carrying out these methods.
申请公布号 US2016068916(A1) 申请公布日期 2016.03.10
申请号 US201514860024 申请日期 2015.09.21
申请人 Pacific Edge Limited 发明人 Nekarda Hjalmar;Friederichs Jan;Holzmann Bernhard;Rosenberg Robert;Reeve Anthony Edmund;Black Michael Alan;McCall John Lindsay;Lin Yu-Hsin;Pollock Robert Craig
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A prognostic signature for determining progression of CRC, comprising two or more genes selected from Tables 1 and 2.
地址 Dunedin NZ